GB Sciences Licenses Patent To Develop New Cannabis-Based Therapies For The Treatment Of Heart Disease
Pharmaceutical Investing Big Pharma Pushes Forward with Alzheimer's R&D but Medicinal Plants May be the Answer
Juggernaut Announces Strategic Investment by Crescat Capital Funds for 28.95% Ownership - Dr. Quinton Hennigh Technical Advisor
